Background Diabetes mellitus (DM) and cardiovascular disease (CVD) are present in a
large number of patients with novel Coronavirus disease 2019 (COVID-19). We aimed to …

Aims: The 2019 novel coronavirus disease (COVID-19) emerged in Wuhan, China, and was
characterized as a pandemic by the World Health Organization. Diabetes is an established …

Background The coronavirus disease 2019 (COVID-19) patients with diabetes mellitus (DM)
are at high risk of fatal outcomes. This meta-analysis quantifies the prevalence of mortality …

Aims COVID-19 is a current global pandemic. However, comprehensive global data
analyses for its mortality risk factors are lacking. The current investigation aimed to assess …

Background Many studies on COVID-19 have reported diabetes to be associated with
severe disease and mortality, however, the data is conflicting. The objectives of this meta …

Background The prognostic significance of diabetes mellitus (DM) in patients with
coronavirus 2019 disease (COVID-19) remains unknown. Objectives To assess the risk of …

Background Currently, the number of patients with SARS-COV-2 infection has increased
rapidly in Iran, but the risk and mortality of SARS-COV-2 infection in Iranian patients with …

Objective This study explores the clinical characteristics of patients with diabetes with severe
covid-19, and the association of diabetes with survival duration in patients with severe covid …

Background and aims While the higher prevalence of diabetes mellitus (DM) at younger age
in Indonesia might contribute to the relatively higher COVID-19 mortality rate in Indonesia …

Background and Aim Currently, the number of patients with coronavirus disease 2019
(COVID-19) infection is increasing rapidly worldwide. In this study, we aimed to assess …